To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·04-04
      ARKG Investment Tracker position change: Decreased position in Natera by 588 shares, the number of shares held decreased 0.26% compared to the previous period and now represents 4.51% of the total position.
      382Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-04
      ARKG Investment Tracker position change: Decreased position in Eli Lilly by 30 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 1.09% of the total position.
      481Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-04
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 4,168 shares, the number of shares held decreased 0.26% compared to the previous period and now represents 2.43% of the total position.
      440Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-04
      ARKG Investment Tracker position change: Decreased position in Veracyte by 5,165 shares, the number of shares held decreased 0.54% compared to the previous period and now represents 2.97% of the total position.
      180Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-04
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 5,062 shares, the number of shares held decreased 0.26% compared to the previous period and now represents 2.2% of the total position.
      163Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-04
      ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 1,198 shares, the number of shares held decreased 0.26% compared to the previous period and now represents 4.12% of the total position.
      357Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-04
      ARKG Investment Tracker position change: Decreased position in CareDx by 5,406 shares, the number of shares held decreased 0.26% compared to the previous period and now represents 3.64% of the total position.
      159Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-04
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 5,016 shares, the number of shares held decreased 0.26% compared to the previous period and now represents 9.36% of the total position.
      432Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-04
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 11,912 shares, the number of shares held decreased 0.26% compared to the previous period and now represents 1.52% of the total position.
      420Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·04-04
      ARKG Investment Tracker position change: Decreased position in Tempus AI by 5,074 shares, the number of shares held decreased 0.26% compared to the previous period and now represents 8.99% of the total position.
      235Comment
      Report
       
       
       
       

      Most Discussed